Consecutive asymptomatic subjects

were selected as contro

Consecutive asymptomatic subjects

were selected as control group with similar survey. Multiple linear regression models were used to analyze risk factors. Results: There was 1031 control. Among 2378 dyspeptic outpatients, 818 fulfilled diagnostic criteria. Selleckchem HDAC inhibitor After investigation, 306 were excluded (243 ulcers, 60 esophagitis). 512 patients (69.9% female mean age 50 years-old) were subjected for final analysis. An overlap (n = 176, 34.4%) between those with EPS (n = 310, 60.5%) and PDS (n = 368, 71.9%) was noted. By multivariable linear regression analysis, the following factors were associated with FD: female (OR:1,81, 95% CI:1.20∼2.74), bet nut chewing (OR:4.58,95% CI1.77∼11.84), NASID (OR:7.55, 95% CI 4.40∼12.96), sleep disturbance (OR:1.63,95%CI1.15∼2.30), anxiety (OR:2.75,95%CI1.85∼4.06), depression (OR:1.89,95%CI1.24∼2.87), H.pylori (OR:1.68,95%CI1.21∼2.33), non-erosive reflux disorder (NERD) (OR:10.57,95%CI7.05∼15.86), irritable bowel syndrome

(IBS) (OR:7.68, 95% CI 4.56∼12.93). The following factors were associated with PDS but not for EPS: drinking (OR:1.63, 95%CI1.00∼2.65), sleep disturbance (OR:2.66, 95%CI1.75∼4.02, Selumetinib depression (OR:1.92, 95%CI1.18∼3.14). Conclusion: FD patients fulfilling Rome III criteria had more NASID usage, sleep disturbance, anxiety, depression, NERD, IBS, and H.pylori infection. Diagnoses of PDS, but not EPS, are independently associated with sleep disturbance, an psychopathology. Key Word(s): 1. functional dyspepsia; Presenting Author: ZHONG YINGQIANG Additional Authors: HUANG HUARONG Corresponding Author: ZHONG YINGQIANG Affiliations: Department of Gastroenterology, Sun Yat-Sen Amine dehydrogenase Memorial Hospital, Sun Yat-sen University; Department of Gastroenterology,

Sun Yat-Sen Memorial Hospital, Sun Yat-sen University Objective: To observe the efficacy, adverse drug reaction and effect the deprssion and anxiety of venlafaxine hydrochloride sustained release table and pinaverium bromide on treating the patients with dominant-diarrhea irritable bowel syndrome (IBS-D). Methods: 403 patients were enrolled the randomized, parallel-control, multi-center and opening study. The study group treated with venlafaxine and pinaverium bromide, and the control treated with pinaverium bromide. The signs described with grading score, and degree of depression or anxiety scored with HAMD and HAMA system, and efficacy assessed with according to the changes of signs score. Results: 94% of patients with IBS-D were comorbided depression or /and anxiety. The features of HAMD were depression, insomnia-middle, lower in work and interesis, agitation, somatic anxiety, gut symptoms, general somatic symptoms and hypochondriasis. The features of HAMA were anxiety mood, tension, insomnia, cognitive disorder, depression and gut symptoms. There were significantly improved symptoms of IBS-D in the study group than in the control after the first week, and more after the second week.

Comments are closed.